Mesoblast (MESO) announced that Jane Bell will retire from her role as chair and will remain on the board as a non-executive director. The board has unanimously appointed Philip Facchina to the role of non-executive chair. Facchina joined the Mesoblast board in March 2021.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MESO:
- Mesoblast Issues 5 Million Unquoted Warrants as Fee for US$50 Million Convertible Note Facility
- Mesoblast’s AGM Results: All Resolutions Passed on November 25, 2025
- Mesoblast Achieves FDA Approval for Ryoncil®
- Mesoblast upgraded to Buy at Jefferies as Ryoncil roll out continues
- Mesoblast upgraded to Buy from Hold at Jefferies